CXCL10 and neoplasm: Considering that IFNγ (Th1 cytokine) and IP-10 (Th1 chemokine) are pharmacodynamic response markers for IL-12 therapy, our results suggest that cytokine mRNA triplet promoted Th1-polarized anti-tumor inflammation.